市场调查报告书
商品编码
1426971
手术止血剂市场,按产品类型(局部凝血酶基、流动性、胶原基、氧化再生纤维素基、明胶基和组合)、配方(基质、海绵、粉末)、应用、最终用途 - 全球预测(2024 -2032)Surgical Hemostats Market, By Product Type (Topical Thrombin-Based, Flowable, Collagen-Based, Oxidized Regenerated Cellulose-Based, Gelatin-Based, & Combination), Formulation (Matrix, Sponge, Powder), Application, End-use -Global Forecast (2024-2032) |
在减少术后併发症的共同努力的推动下,2024 年至 2032 年,手术止血剂市场规模预计将以 5.6% 的CAGR扩大。
最近,外科医生正在优先考虑有效的止血解决方案来控製手术过程中和手术后的出血,以降低併发症的风险并改善患者的预后。医疗保健专业人员越来越重视患者的安全和康復,从而大量采用先进的止血剂。创新止血技术的不断发展旨在提高功效并最大限度地减少不良反应,这将推动产品的采用。此外,止血剂的持续创新,包括开发先进材料和配方以提高功效和适用性,将有助于产业成长。例如,2023年11月,Ethicon宣布批准ETHIZIATM,这是一种经过临床认证的补充止血解决方案,用于在难以控制出血的情况下维持止血。
该行业分为产品类型、配方、应用、最终用途和地区。
根据产品类型,预计 2024 年至 2032 年间,胶原蛋白手术止血剂市场的CAGR将达到5.2%。这是由于胶原蛋白产品因其多功能性和有效控制出血的能力而受到越来越多的青睐。手术止血剂在各种手术应用中具有止血功效、生物相容性和易用性。此外,胶原蛋白的天然止血特性使其在各种手术中的应用激增,包括骨科、心血管和牙科手术。此外,提高胶原蛋白止血剂性能和适用性的技术进步将推动该领域的成长。
就最终用途而言,到 2032 年,门诊手术中心领域的手术止血剂行业预计将实现 5.4% 的增长率。患者对门诊手术中心 (ASC) 医疗治疗的日益偏好可归因于其效率、成本-有效性和微创手术。在门诊环境中进行的各种外科手术中,对有效控制出血的需求不断增长,也刺激了产品需求。
由于外科手术的增加、医疗保健基础设施的增加以及对先进医疗产品的认识不断增强,亚太地区手术止血剂产业预计在 2024 年至 2032 年期间将呈现 6% 的成长率。慢性病和择期手术的盛行率激增,导致对高效止血解决方案的需求更高。此外,政府促进医疗保健发展的倡议,加上手术技术的不断进步以及对尽量减少术后併发症的高度重视,将加速区域产业的扩张。
Surgical Hemostats Market size is poised to expand at 5.6% CAGR from 2024 to 2032 driven by the concerted efforts to minimize postoperative complications.
Of late, surgeons are prioritizing effective hemostatic solutions to control bleeding during and after surgical procedures for reducing the risk of complications and improving patient outcomes. Healthcare professionals are increasingly emphasizing patient safety and recovery, surging the adoption of advanced hemostatic agents. The continuous development of innovative hemostatic technologies, aimed at enhancing efficacy and minimizing adverse effects will fuel the product adoption. Furthermore, the ongoing innovations in hemostatic agents, including the development of advanced materials and formulations to improve efficacy and applicability will contribute to the industry growth. For instance, in November 2023, Ethicon announced the approval of ETHIZIATM, a clinically certified supplementary hemostat solution to maintain hemostasis in circumstances of difficult-to-control bleeding.
The industry is segmented into product type, formulation, application, end-use, and region.
Based on product type, the collagen-based surgical hemostats market is projected to witness 5.2% CAGR between 2024 and 2032. This is owing to the increasing preference for collagen-based products for their versatility and ability to control bleeding effectively. Surgical hemostats provide hemostatic efficacy, biocompatibility, and ease of use in various surgical applications. Additionally, the natural hemostatic properties of collagen are surging its use for diverse surgeries, including orthopedic, cardiovascular, and dental procedures. Furthermore, technological advancements to enhance the performance and applicability of collagen-based hemostats will propel the segment growth.
In terms of end-use, the surgical hemostats industry from the ambulatory surgical centers segment is expected to record 5.4% growth rate through 2032. The growing patient preference for medical treatments at ambulatory surgical centers (ASCs) can be attributed to their efficiency, cost-effectiveness, and minimally invasive procedures. The rising need for effective bleeding control in diverse surgical interventions performed in outpatient settings is also fueling the product demand.
Asia Pacific surgical hemostats industry is set to exhibit 6% growth rate during 2024-2032 attributed to the rising surgical procedures, increasing healthcare infrastructure, and the growing awareness about advanced medical products. The surging prevalence of chronic diseases and elective surgeries is contributing to the higher demand for efficient hemostatic solutions. Moreover, government initiatives for promoting healthcare development coupled with the ongoing advancements in surgical techniques and the strong focus on minimizing postoperative complications will accelerate the regional industry expansion.